No.
|
日付
|
Title:
|
Journal
|
PMID.
|
担当者
|
まとめ
|
18
|
6th/March
|
Japanese subgroup analysis
of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.
|
International Journal of Clinical Oncology 2019
|
30830659
|
福田
|
児玉
|
17
|
20th/Feb
|
Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK
Study.
|
JTO 2018
|
30217492
|
児玉
|
児玉
|
16
|
16th/Jan
|
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
|
NEJM2018
|
29658848
|
金澤
|
石井
|
15
|
9th Jan
|
Angiotensin converting enzyme inhibitors and risk of lung cancer:
population based cohort study
|
BMJ2018
|
30355745
|
大越
|
児玉
|
14
|
20th/Dec
|
Three new disease-progression modes in NSCLC patients after
EGFR-TKI treatment by next-generation sequencing analysis.
|
Lung Cancer2018
|
30429037
|
児玉
|
児玉
|
13
|
20th/Nov
|
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
|
NEJM 2018
|
30280641
|
井部
|
児玉
|
12
|
7th/Nov
|
Novel
therapies for malignant pleural mesothelioma
|
Lancet 2018
|
29508763
|
濵元
|
児玉
|
11
|
24th/Oct
|
Impact
of Baseline Steroids on Efficacy of Programmed Cell Death-1 and
Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer
|
JCO 2018
|
30125216
|
大越
|
石井
|
10
|
10th/Oct
|
Influenza
vaccination of cancer patients during PD-1 blockade induces serological protection but
may raise the risk for immune-related adverse events
|
J. Immunotherapy of Cancer 2018
|
29789020
|
坂木
|
石井
|
9
|
3rd/Oct
|
Safety of
Programmed Death-1 Pathway Inhibitors Among Patients With Non-Small-Cell Lung Cancer and Preexisting Autoimmune Disorders
|
JCO 2018
|
29746230
|
皆川
|
児玉
|
8
|
12th/July
|
Cancer immunotherapy efficacy and patients’ sex: a systematic review and meta-analysis
|
Lancet 2018
|
29778737
|
岡崎
|
児玉
|
7
|
20th/June
|
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
|
NEJM 2018
|
29863955
|
児玉
|
児玉
|
6
|
13th/June
|
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients
With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
|
JCO 2018
|
29746227
|
加世田
|
児玉
|
5
|
23rd/May
|
Outpatient
Talc Administration by Indwelling Pleural Catheter for Malignant Effusion
|
NEJM 2018
|
29617585
|
森山
|
児玉
|
4
|
16th/May
|
Nivolumab
plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
|
NEJM 2018
|
29658845
|
濵元
|
児玉
|
3
|
25th/Apr
|
Predictive performance of the quick
Sequential Organ Failure Assessment score as a
screening
tool for
sepsis, mortality, and intensive care unit admission in patients with febrile neutropenia
|
Suppoet Care Cancer
2018
|
28062972
|
坂木
|
児玉
|
2
|
18th/Apr
|
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
|
NEJM 2018
|
29658856
|
児玉
|
児玉
|
1
|
4th/Apr
|
Outcomes in
patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic
study
|
Lancet 2018
|
29249325
|
井部
|
児玉
|